Farrell Michael J. 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed May 27, 2026

AI-generated summary of this filing

Updated May 27, 2026

Zimmer Biomet (ZBH) Director Michael J. Farrell Receives Awards

What Happened

Michael J. Farrell, a director of Zimmer Biomet Holdings (ZBH), was granted two awards on 2026-05-22: 875.350 phantom stock units and 1,517.274 restricted stock units (total 2,392.624 units). Both awards have an acquisition/strike price of $0.00 (they are grants, not purchases) and are reported as derivative securities.

Key Details

Transaction date: 2026-05-22; Form 4 filed: 2026-05-27 (filed after the typical two-business-day deadline for Form 4; the filing appears late).
Awards and amounts: 875.350 phantom stock units (F1) and 1,517.274 restricted stock units (RSUs) (F5). Total = 2,392.624 units.
Price: $0.00 per unit (these are awards/grants, not cash purchases).
Conversion: Derivative conversion/exercise is 1-for-1 into common shares (F2).
Settlement/deferral: Phantom units are to be settled in shares within 60 days after the director stops service (F3). The RSUs are immediately 100% vested but subject to mandatory deferral until the later of the reporting person’s termination as a director or three years after the grant date (F5). Some RSUs granted in prior years remain subject to different deferral schedules (F6).
Dividend credit: The phantom units include 53.557 units credited under the plan’s dividend reinvestment provision (F4).
Shares owned after transaction: Not specified in the filing.

Context

These are awards (not open-market purchases or sales). Phantom stock units and RSUs give the holder economic exposure to company stock but may be settled and/or deferred per plan rules; they do not provide immediate cash proceeds or indicate a sale. The filing shows no immediate sale or exercise-for-cash.

Form 4

Period: 2026-05-22

Director

Transactions

Award
Phantom Stock Units
[F1][F2][F3][F4]
2026-05-22+875.35→ 19,173.94 total
Exercise: $85.68→ Common Stock (875.35 underlying)
Award
Restricted Stock Units
[F2][F5][F6]
2026-05-22+1,517.274→ 13,757 total
→ Common Stock (1,517.274 underlying)

Footnotes (6)

[F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3]Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
[F4]Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.
[F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Signature

/s/ Matthew R. St. Louis, Attorney-in-Fact for Michael J. Farrell (power of attorney previously filed)|2026-05-27

1 file